1. Home
  2. NMRA vs DSP Comparison

NMRA vs DSP Comparison

Compare NMRA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • DSP
  • Stock Information
  • Founded
  • NMRA 2019
  • DSP 1999
  • Country
  • NMRA United States
  • DSP United States
  • Employees
  • NMRA N/A
  • DSP N/A
  • Industry
  • NMRA
  • DSP EDP Services
  • Sector
  • NMRA
  • DSP Technology
  • Exchange
  • NMRA Nasdaq
  • DSP Nasdaq
  • Market Cap
  • NMRA 287.6M
  • DSP 291.3M
  • IPO Year
  • NMRA 2023
  • DSP 2021
  • Fundamental
  • Price
  • NMRA $0.66
  • DSP $14.12
  • Analyst Decision
  • NMRA Buy
  • DSP Strong Buy
  • Analyst Count
  • NMRA 8
  • DSP 8
  • Target Price
  • NMRA $9.29
  • DSP $21.75
  • AVG Volume (30 Days)
  • NMRA 891.0K
  • DSP 263.8K
  • Earning Date
  • NMRA 05-12-2025
  • DSP 05-06-2025
  • Dividend Yield
  • NMRA N/A
  • DSP N/A
  • EPS Growth
  • NMRA N/A
  • DSP N/A
  • EPS
  • NMRA N/A
  • DSP 0.13
  • Revenue
  • NMRA N/A
  • DSP $306,484,000.00
  • Revenue This Year
  • NMRA N/A
  • DSP $19.25
  • Revenue Next Year
  • NMRA N/A
  • DSP $16.72
  • P/E Ratio
  • NMRA N/A
  • DSP $109.37
  • Revenue Growth
  • NMRA N/A
  • DSP 30.64
  • 52 Week Low
  • NMRA $0.62
  • DSP $8.62
  • 52 Week High
  • NMRA $17.19
  • DSP $26.33
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 31.99
  • DSP 55.48
  • Support Level
  • NMRA $0.63
  • DSP $12.58
  • Resistance Level
  • NMRA $0.72
  • DSP $15.31
  • Average True Range (ATR)
  • NMRA 0.06
  • DSP 0.80
  • MACD
  • NMRA 0.02
  • DSP 0.15
  • Stochastic Oscillator
  • NMRA 18.80
  • DSP 81.76

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. Through the technology, a marketer can easily buy ads on desktop, mobile, connected TV, linear TV, streaming audio and digital billboards.

Share on Social Networks: